Erectile function preservation after radiotherapy using a dose-optimization approach on sexual structures for localized prostate cancer
CONCLUSION: This approach with dose-optimization on sexual structures for localized prostate cancer found excellent results on erectile function preservation after radiotherapy, with 78% of the patients with no or mild erectile dysfunction at 2 years.PMID:38599939 | DOI:10.1016/j.canrad.2023.08.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: A Chardon C Udrescu A Beneux A Ruffion S Horn A Lapierre O Chapet Source Type: research
Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers
This article does not discuss the indications of external radiotherapy (nor concurrent systemic treatment) but focuses on target volumes when there is an indication for radiotherapy.PMID:38599940 | DOI:10.1016/j.canrad.2023.12.001 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: F Guillemin P Blanchard P Boisselier Y Brahimi V Calugaru A Coutte P Gillon P Graff X Liem A Modesto Y Pointreau S Racadot X S Sun R Bellini N Pham Dang N Saroul J Bourhis J Thariat J Biau M Lapeyre Source Type: research
Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams
CONCLUSION: This proof-of-concept study shows that proton minibeam radiotherapy can achieve a homogeneous coverage of an arrhythmogenic cardiac zone, reducing the dose at the normal tissues. This technique, ensuring could theoretically reduce the risk of late pulmonary and breast fibrosis, as well as cardiac toxicity as seen in previous biological studies in proton minibeam radiotherapy.PMID:38599941 | DOI:10.1016/j.canrad.2024.02.002 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: P Loap M Giorgi J Vu-Bezin K Kirov J M Sampai Y Prezado Y Kirova Source Type: research
Erectile function preservation after radiotherapy using a dose-optimization approach on sexual structures for localized prostate cancer
CONCLUSION: This approach with dose-optimization on sexual structures for localized prostate cancer found excellent results on erectile function preservation after radiotherapy, with 78% of the patients with no or mild erectile dysfunction at 2 years.PMID:38599939 | DOI:10.1016/j.canrad.2023.08.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: A Chardon C Udrescu A Beneux A Ruffion S Horn A Lapierre O Chapet Source Type: research
Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers
This article does not discuss the indications of external radiotherapy (nor concurrent systemic treatment) but focuses on target volumes when there is an indication for radiotherapy.PMID:38599940 | DOI:10.1016/j.canrad.2023.12.001 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: F Guillemin P Blanchard P Boisselier Y Brahimi V Calugaru A Coutte P Gillon P Graff X Liem A Modesto Y Pointreau S Racadot X S Sun R Bellini N Pham Dang N Saroul J Bourhis J Thariat J Biau M Lapeyre Source Type: research
Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams
CONCLUSION: This proof-of-concept study shows that proton minibeam radiotherapy can achieve a homogeneous coverage of an arrhythmogenic cardiac zone, reducing the dose at the normal tissues. This technique, ensuring could theoretically reduce the risk of late pulmonary and breast fibrosis, as well as cardiac toxicity as seen in previous biological studies in proton minibeam radiotherapy.PMID:38599941 | DOI:10.1016/j.canrad.2024.02.002 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: P Loap M Giorgi J Vu-Bezin K Kirov J M Sampai Y Prezado Y Kirova Source Type: research
Erectile function preservation after radiotherapy using a dose-optimization approach on sexual structures for localized prostate cancer
CONCLUSION: This approach with dose-optimization on sexual structures for localized prostate cancer found excellent results on erectile function preservation after radiotherapy, with 78% of the patients with no or mild erectile dysfunction at 2 years.PMID:38599939 | DOI:10.1016/j.canrad.2023.08.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: A Chardon C Udrescu A Beneux A Ruffion S Horn A Lapierre O Chapet Source Type: research
Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers
This article does not discuss the indications of external radiotherapy (nor concurrent systemic treatment) but focuses on target volumes when there is an indication for radiotherapy.PMID:38599940 | DOI:10.1016/j.canrad.2023.12.001 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: F Guillemin P Blanchard P Boisselier Y Brahimi V Calugaru A Coutte P Gillon P Graff X Liem A Modesto Y Pointreau S Racadot X S Sun R Bellini N Pham Dang N Saroul J Bourhis J Thariat J Biau M Lapeyre Source Type: research
Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams
CONCLUSION: This proof-of-concept study shows that proton minibeam radiotherapy can achieve a homogeneous coverage of an arrhythmogenic cardiac zone, reducing the dose at the normal tissues. This technique, ensuring could theoretically reduce the risk of late pulmonary and breast fibrosis, as well as cardiac toxicity as seen in previous biological studies in proton minibeam radiotherapy.PMID:38599941 | DOI:10.1016/j.canrad.2024.02.002 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: P Loap M Giorgi J Vu-Bezin K Kirov J M Sampai Y Prezado Y Kirova Source Type: research
Erectile function preservation after radiotherapy using a dose-optimization approach on sexual structures for localized prostate cancer
CONCLUSION: This approach with dose-optimization on sexual structures for localized prostate cancer found excellent results on erectile function preservation after radiotherapy, with 78% of the patients with no or mild erectile dysfunction at 2 years.PMID:38599939 | DOI:10.1016/j.canrad.2023.08.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: A Chardon C Udrescu A Beneux A Ruffion S Horn A Lapierre O Chapet Source Type: research
Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers
This article does not discuss the indications of external radiotherapy (nor concurrent systemic treatment) but focuses on target volumes when there is an indication for radiotherapy.PMID:38599940 | DOI:10.1016/j.canrad.2023.12.001 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: F Guillemin P Blanchard P Boisselier Y Brahimi V Calugaru A Coutte P Gillon P Graff X Liem A Modesto Y Pointreau S Racadot X S Sun R Bellini N Pham Dang N Saroul J Bourhis J Thariat J Biau M Lapeyre Source Type: research
Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams
CONCLUSION: This proof-of-concept study shows that proton minibeam radiotherapy can achieve a homogeneous coverage of an arrhythmogenic cardiac zone, reducing the dose at the normal tissues. This technique, ensuring could theoretically reduce the risk of late pulmonary and breast fibrosis, as well as cardiac toxicity as seen in previous biological studies in proton minibeam radiotherapy.PMID:38599941 | DOI:10.1016/j.canrad.2024.02.002 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: P Loap M Giorgi J Vu-Bezin K Kirov J M Sampai Y Prezado Y Kirova Source Type: research
Erectile function preservation after radiotherapy using a dose-optimization approach on sexual structures for localized prostate cancer
CONCLUSION: This approach with dose-optimization on sexual structures for localized prostate cancer found excellent results on erectile function preservation after radiotherapy, with 78% of the patients with no or mild erectile dysfunction at 2 years.PMID:38599939 | DOI:10.1016/j.canrad.2023.08.010 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: A Chardon C Udrescu A Beneux A Ruffion S Horn A Lapierre O Chapet Source Type: research
Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers
This article does not discuss the indications of external radiotherapy (nor concurrent systemic treatment) but focuses on target volumes when there is an indication for radiotherapy.PMID:38599940 | DOI:10.1016/j.canrad.2023.12.001 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: F Guillemin P Blanchard P Boisselier Y Brahimi V Calugaru A Coutte P Gillon P Graff X Liem A Modesto Y Pointreau S Racadot X S Sun R Bellini N Pham Dang N Saroul J Bourhis J Thariat J Biau M Lapeyre Source Type: research
Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams
CONCLUSION: This proof-of-concept study shows that proton minibeam radiotherapy can achieve a homogeneous coverage of an arrhythmogenic cardiac zone, reducing the dose at the normal tissues. This technique, ensuring could theoretically reduce the risk of late pulmonary and breast fibrosis, as well as cardiac toxicity as seen in previous biological studies in proton minibeam radiotherapy.PMID:38599941 | DOI:10.1016/j.canrad.2024.02.002 (Source: Cancer Radiotherapie)
Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: P Loap M Giorgi J Vu-Bezin K Kirov J M Sampai Y Prezado Y Kirova Source Type: research
